Navigation Links
Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
Date:5/1/2008

Quarterly Cash Dividend Provides an Annualized Yield of 10.4%

LARGO, Fla., May 1 /PRNewswire-FirstCall/ -- The Unilens Vision Inc. (OTC Bulletin Board: UVICF) (TSX Venture Exchange: UVI) Board of Directors today declared its regular quarterly cash dividend of U.S. $0.09 per common share, payable May 28, 2008 to stockholders of record at the close of business on May 14, 2008.

"We are pleased to continue the U.S. $0.09 per share quarterly dividend, which on a annualized dividend rate of U.S. $0.36 per share provides a dividend yield of 10.4% based on the closing price of our common stock in the U.S. on Wednesday April 30, 2008," stated Michael J. Pecora, Chief Executive Officer of Unilens Vision Inc.

About Unilens Vision Inc. - "The Eye Care Professionals Specialty Contact Lens Company"

Established in 1989, Unilens Vision Inc., through its wholly owned subsidiary Unilens Corp., USA, located in Largo, Florida, develops, licenses, manufactures, distributes and markets specialty contact lenses under the C-Vue, Unilens, Sof-Form, Aquaflex, SoftCon, Lombart, and LifeStyle brands. Additional information on the Company may be accessed on the Internet at http://www.unilens.com. The Company's common stock is listed on the OTC Bulletin Board under the symbol "UVICF" as well as the Canadian TSX Venture Exchange under the symbol "UVI".

(Note: All financial information in this release is stated in U.S. Dollars.)

The information contained in this news release, other than historical information, consists of forward-looking statements that involve risk and uncertainties that could cause actual results to differ materially from those described in such statements. For a discussion of certain factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to the Company's most recent filings with the SEC and the TSX Vent
'/>"/>

SOURCE Unilens Vision Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Unilens Vision Reports 70% Increase in Second Quarter Earnings on Higher Sales and Record Royalty Income
2. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
3. Unilens Vision Reports Record First Quarter Earnings and Royalty Income
4. Unilens Names Eschenbach Optik Exclusive Worldwide Distributor of the UniVision(R) Low Vision Lens
5. Study by Texas A&M University-Corpus Christi Confirms Training With Vision Software Enhances Hitting Skills
6. Sharing Miracles Television Program to Feature Leave it to Beaver Star Jerry Mathers
7. Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology Meeting
8. Retirement Living TV Partners with Maryland Public Television to Address the Issue of Healthcare in America Through Its Series Healthcare 08: Search for Solutions
9. American Humane Forms Human-Animal Bond Division, Including Animal-Assisted Therapy, Humane Ed and Pets & Womens Shelters
10. Therap Services to Host Conference in Association with the Delaware Division of Developmental Disabilities Services
11. Yeast gives rise to new concept: cell fuel is brains behind division
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...Newswire/ -- Public interest,advocates(1) welcomed...decisions on the threats posed by mercury to human... 2nd UNEP(2) Open Ended Working Group (OEWG2) on,M... of a global framework,on mercury, in preparation ...09, where it will be decided whether a global lega...
(Date:10/10/2008)...Technology Evolution: Smarter Solutions for Better... (PRWEB) September 17, 2008 -- The New Jersey and ...e Information Management Systems Society ( HIMSS )...mation technology professionals together for a two...echnology Evolution: Smarter Solutions for Better ...
(Date:10/10/2008)... Johns Hopkins University School,of Medicine is la...ptimizing Adjuvant Breast Cancer Strategies: From ...ent key research data on the latest advances in,br...ents in the treatment of breast cancer have,led to...ons that are,increasingly tailored to the specific...
(Date:10/9/2008)...e Accredited Course for,Non-Dermatologists about D...ovember 1, 2008 at the Royal Sonesta Hotel Boston,...e-USNewswire/ -- The Melanoma,Foundation of New En... are,co-sponsoring an Accreditation Council for Co...e non-dermatologists on the detection and manageme...
Breaking Medicine News(10 mins):Health News:Elements for a UN Global Framework on Mercury Agreed to 2Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2Health News:Paul Sullivan's Legacy: An Early Warning Program for Detecting Melanoma Before It's Too Late 2
...ked, President A.P.J. Abdul Kalam Thursday said th...ill women// who have no home. "While mental illne...themselves but also for their families, it becomes...ir families," Kalam said here at the beginning of ...
...ation of kidney diseases worldwide. According to s...are in the throes of kidney related ailments. Rep...o avoid kidney transplant is to detect the disease...s simply unaffordable for majority of the people i...
...e physicians are knowledgeable about women’s sleep...’ sleep problems. The survey issued by American Co...). It was found that most pulmonary/critical care ...erns of their female patients and are advising app...
...tt, urging the Commonwealth to convince the States...nd performance benchmarks for medical training in ... (AHCA) negotiations. The current AHCA expires i... the next agreement commence soon. AMA President...
Other Medicine News:Health News:Nearly 2,500 Mentally Ill Women in Delhi are Destitute: Abdul Kalam 2Health News:Doctors Not Drowsy When Treating Women’s Sleep Issue 2Health News:Doctors Not Drowsy When Treating Women’s Sleep Issue 3
(Date:10/8/2008)...(R) Element(TM) Platinum Chromium ...ewswire-FirstCall/ -- Boston Scientific,Corporatio...ted enrollment in,the PERSEUS trial, designed to e...ement(TM) paclitaxel-eluting coronary stent. The P...patients at 100 U.S. and,international centers sin...
(Date:10/7/2008)...etheus Laboratories Inc., a,specialty pharmaceutic...lopment of PROMETHEUS(R) IBS Diagnostic, the first...(IBS). The findings suggest measurable,differences...od samples,between IBS and non-IBS patients. The i... proprietary algorithm, led to the development of ...
(Date:10/7/2008)...e Osteoarthritis Research Society,International,s ...Newswire/ -- Ferring Pharmaceuticals Inc.,recently...thritis of the,Knee, showing that EUFLEXXA(R) (1% ...molecular weight form of intra-articular hyaluroni...ine (IA-saline) for the relief,of pain in knee ost...
(Date:10/7/2008)... taken once-daily significantly,improved the sympt... /- Shire plc (LSE: SHP,Na...al company, today,announced that a study published... Psychiatry found once-daily VYVANSE significantly... (ADHD) symptoms in adults within,the first week o...
Breaking Medicine Technology:Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 5Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 6About one quarter of women with HIV want to become pregnant 12652 1About one quarter of women with HIV want to become pregnant 12652 2About one quarter of women with HIV want to become pregnant 12652 3About one quarter of women with HIV want to become pregnant 12652 4Danaher to Present at Citigroup Global Industrial Manufacturing Conference 12649 1Three Year Analysis of Treatment Efficacy Cosmesis and Toxicity Support use of the Hologic Mammosite Radiation Therapy System 1428 1Three Year Analysis of Treatment Efficacy Cosmesis and Toxicity Support use of the Hologic Mammosite Radiation Therapy System 1428 2Three Year Analysis of Treatment Efficacy Cosmesis and Toxicity Support use of the Hologic Mammosite Radiation Therapy System 1428 3Three Year Analysis of Treatment Efficacy Cosmesis and Toxicity Support use of the Hologic Mammosite Radiation Therapy System 1428 4Antibiotic Use in Dementia Patients Questioned 12644 1Antibiotic Use in Dementia Patients Questioned 12644 2Antibiotic Use in Dementia Patients Questioned 12644 3
...essed protein,protects human pancreatic cancer cel...g one of the body,s natural defenses against,out-o...ty of Texas,M. D. Anderson Cancer Center report in...he protein tissue transglutaminase, known by the a...archers at M. D. Anderson and,elsewhere to be over...
...Clinical studies have,shown (1) similar rates of n...uenza patients being treated with Tamiflu compared...za. Furthermore,recent data derived from US healt...101,000 influenza patients treated with Tamiflu,an...lu have shown,that the Tamiflu treated patients sh...
Other Medicine Technology:Protein Found to Shield Pancreatic Cancer Cells from,Self-Destruction 2Protein Found to Shield Pancreatic Cancer Cells from,Self-Destruction 3New Data from the US and Japan Support: No Established Causal Link,Between Neuropsychiatric Symptoms and Treatment with Tamiflu US,Databases Indicate Psychiatric Symptoms Lower in Influenza Patients,Taking Tamiflu Versus Those Not Taking Tamiflu 2New Data from the US and Japan Support: No Established Causal Link,Between Neuropsychiatric Symptoms and Treatment with Tamiflu US,Databases Indicate Psychiatric Symptoms Lower in Influenza Patients,Taking Tamiflu Versus Those Not Taking Tamiflu 3New Data from the US and Japan Support: No Established Causal Link,Between Neuropsychiatric Symptoms and Treatment with Tamiflu US,Databases Indicate Psychiatric Symptoms Lower in Influenza Patients,Taking Tamiflu Versus Those Not Taking Tamiflu 4
Duckbill. 3.5 mm tip. Light curve.
Duckbill type, sharp. 3 mm x 8 mm curved blade. Octagonal handle.
4 mm x 9 mm tip.
2 mm curved tip. Round handle. Designated most popular model or size.
Medicine Products: